Israeli digital-health startup YuviTal has been chosen to lead a new initiative aimed at improving care for women undergoing breast cancer treatment. The selection follows a joint competition organized by Startup Nation Central, Roche Israel, and Sheba Medical Center, designed to identify technologies that can make a meaningful impact on patient care.
As part of the program, YuviTal will launch a clinical pilot at Sheba’s Breast Cancer Institute. The company will receive an NIS 50,000 award, additional funding of up to NIS 200,000, a yearlong membership at Sheba’s innovation hub ARC, and ongoing guidance from Roche specialists and Sheba oncologists. The pilot will assess how YuviTal’s platform performs in daily clinical practice and whether it can improve the treatment experience for patients.
YuviTal’s technology collects continuous, real-world data on behavior, mood, diet, and general wellness. It uses this information to generate personalized recommendations and alert clinicians to early changes in a patient’s condition. The system is designed to help women maintain stability during treatment while providing medical teams with better insight into their daily challenges.
This year’s competition was part of Roche’s “Roche for a Better Future” program, which explores new strategies for treatment adherence and disease management. Judges included senior clinicians and innovation leaders from Sheba, Hadassah, Rambam, the Technion, and industry groups such as 8400 and Almeda Ventures.
Program partners emphasized the opportunity to combine Israel’s digital expertise with pressing healthcare needs. “Roche is a global leader in breast cancer thanks to the development of breakthrough treatments,” said Avi Danziger, general manager of Roche Pharma Israel. He added that the winning technology will advance with support from both company and hospital experts.
Startup Nation Central CEO Avi Hasson described the collaboration as a way for Israeli innovation to address growing healthcare demands. Avner Halperin, head of Sheba Impact, said partnerships like this reflect the hospital’s long-term vision for medical innovation.
Related topic：
